Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 12, 2020

Study Completion Date

February 1, 2021

Conditions
Type 2 Diabetes MellitusPrediabetic StateChronic Periodontitis
Interventions
DRUG

Indocyanine green

Single application of PDT will be performed. A diode laser (HELBO®TheraLite - Bredent Medical, Germany) with 670 nm wavelength, power of 150 mW, fluency of 22 J/cm2 and density of 1.1 W/cm2 will be used in this study. Indocyanine-green photosensitizer (Sigm Aldrich, USA) with 0.005% concentration will be used as a photosensitizer which will be applied inside the periodontal pockets in a depth of 3 mm with the help of a blunt needle for 10 s. Laser irradiation will be performed for 60 s using a flexible tip. Laser irradiation will be performed at 2 points each on buccal and lingual with the tip stabilized perpendicular to the gingival tissues.

Trial Locations (1)

11454

College of Applied Medical Sciences, King Saud University, Riyadh

All Listed Sponsors
lead

King Saud University

OTHER

NCT04857346 - Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus | Biotech Hunter | Biotech Hunter